SCHEMBL6354470

SCHEMBL6354470

CC(C)(C)Cc1cccc(O)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 4/20 0.48
GABRA1 P14867 2/20 0.48
GABRB2 P47870 2/20 0.48
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CA2 P00918 2/20 0.46
ADAMTS4 O75173 1/20 0.46
EGFR P00533 1/20 0.46
CA1 P00915 1/20 0.46
FYN P06241 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
CA6 P23280 1/20 0.46
CDK2 P24941 1/20 0.46
MMP12 P39900 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL347746 0.89 GABRA1 (0.61) IAPPGABRA1GABRB2ALDH1A1CA2
SCHEMBL29356321 0.85 IAPP (0.47) IAPPGABRA1GABRB2ALDH1A1LMNA
SCHEMBL314108 0.83 GABRA1 (0.54) GABRA1GABRB2CA2RIPK1ESR1
SCHEMBL674324 0.82 HSPA5 (0.54) ALDH1A1HSD17B10CA2TDP1RIPK1
SCHEMBL24589309 0.81 ALDH1A1 (0.52) GABRA1GABRB2ALDH1A1HPGDHSD17B10
SCHEMBL2019599 0.81 GABRA1 (0.41) IAPPGABRA1GABRB2ALDH1A1TDP1
SCHEMBL6348843 0.80 ESR1 (0.41) GABRA1GABRB2RIPK1ESR1
SCHEMBL28092551 0.80 HSPA5 (0.52) ALDH1A1HSD17B10CA2TDP1RIPK1
SCHEMBL70065 0.79 GABRA1 (0.76) IAPPGABRA1GABRB2ALDH1A1LMNA
SCHEMBL30023472 0.79 GABRA1 (0.76) IAPPGABRA1GABRB2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202474-B2 Process for producing polydienes BRIDGESTONE CORPORATION (JP) 2019-02-12 US claimed
US-20170073443-A1 PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (US) 2017-03-16 US claimed
US-10822318-B2 Lactone-based probes and methods of use thereof REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2020-11-03 US disclosed
US-10202474-B2 Process for producing polydienes BRIDGESTONE CORPORATION (JP) 2019-02-12 US disclosed
US-20170073443-A1 PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (US) 2017-03-16 US disclosed
US-20120022040-A1 ANTIMICROBIALS AMPLYX PHARMACEUTICALS, INC. 2012-01-26 US disclosed
US-6878659-B2 Solid catalyst component for olefin polymerization and catalyst TOHO TITANIUM CO., LTD. (JP) 2005-04-12 US disclosed
US-20040072681-A1 Solid catalyst component for olefin polymerization and catalyst TOHO TITANIUM CO., LTD. (JP) 2004-04-15 US disclosed
EP-1260524-A1 SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST Toho Titanium Co., Ltd. (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022040-A1 ANTIMICROBIALS PAM, MPO, OXA1L IAPP 988/4885GABRA1 3593/4885GABRB2 4510/4885
US-10822318-B2 Lactone-based probes and methods of use thereof MRPL21, QPCTL, ARGLU1 IAPP 3981/4885GABRA1 2754/4885GABRB2 3167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.